With shares of Wal-Mart (NYSE:WMT) trading around $77, is WMT an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s Movement
Wal-Mart�operates retail stores in various formats worldwide. The company operates in three segments: Walmart U.S., Walmart International, and Sam’s Club. It operates retail stores, restaurants, discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, apparel stores, Sam�s Clubs, neighborhood markets, and other small formats, as well as walmart.com; and samsclub.com. Wal-Mart offers a wide variety of products at very competitively prices to demanding consumers at just about every part of the world. Consumers and businesses will continue to shop at Wal-Mart because of the convenience, affordability, and selection that its stores offers. As developing countries continue to grow, Wal-Mart is well-positioned to provide essential products and services to the people and businesses of these countries.
Top High Dividend Companies To Own For 2015: DARA Biosciences Inc.(DARA)
DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. Its products include Soltamox for the treatment of breast cancer; Gemcitabine for first-line therapy for ovarian, breast, lung and pancreatic cancers; and other cancer support therapeutics, as well as generic sterile injectable cytotoxic products. Its drug development programs include KRN5500, a non-narcotic/non-opioid that has completed Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959, which has completed a Phase I study for the treatment of metabolic diseases, including type 2 diabetes and dyslipidemia. The company?s pre-clinical drug candidate includes DB900 PPAR gamma/alpha/delta agonists for development in metabolic and inflammatory diseases; DB160, DPPIV enzyme inhibitors with applications in diabetes, stem cell transpl antation, and cancer therapy; and DB200, Carnitine palmitoyltransferase-1 for skin diseases, including psoriasis. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By Bryan Murphy]
Without knowing the whole story, it would be easy to dismiss the big 9% jump from DARA Biosciences Inc. (NASDAQ:DARA) today as nothing more than a little volatility.... bullishness that wasn't destined to linger, especially considering how ugly the market turned in Monday's trading. As is always the case, though, with DARA, there's more to the story. Today's move may well be the official beginning of a much bigger, trade-worthy rally.
5 Best Supermarket Stocks To Watch For 2014: Guggenheim S&P 500 Pure Growth ETF (RPG)
Rydex S&P 500 Pure Growth ETF (the Fund) seeks to replicate as closely as possible the performance of the S&P 500/Citigroup Pure Growth Index (the Index). The S Index is narrow in focus, containing only those S&P 500 companies with strong growth characteristics as selected by Standard & Poor��. The Index contains approximately one-third of the equities of the S&P 500 Index.
The Fund uses a passive management strategy to track the performance of the Index. The Fund invests in substantially all of the securities in the Index in approximately the same proportions as in the Index. The Fund's investment advisor is Rydex Investments.
Advisors' Opinion:- [By John Udovich]
Yesterday, small cap geothermal stock U.S. Geothermal Inc (NYSEMKT: HTM) produced a geyser of a return when it surged 26.79%, meaning its worth taking a closer look at the stock verses the performance of other geothermal stocks like small cap Ormat Technologies, Inc (NYSE: ORA) and mid cap Calpine Corporation (NYSE: CPN).�First of all, I should mention there are some other geothermal stocks out there like Alterra Power Corp (CVE: AXY) and Ram Power Corp (TSE: RPG) who have their primary listing on Canadian exchanges with secondary ones on the OTC���meaning they may not be a good deal for American investors or easy to invest in. Second, U.S. Geothermal Inc itself is a good geothermal proxy as its�focused on developing, owning, and operating clean, sustainable electric power from geothermal energy resources and its�operating geothermal power projects at Neal Hot Springs, Oregon; San Emidio, Nevada; and Raft River, Idaho plus El Ceibillo, an advanced stage, geothermal prospect located within a 24,710 acre energy rights concession area near Guatemala City, the largest city in Central America.
5 Best Supermarket Stocks To Watch For 2014: Ocera Therapeutics Inc (OCRX)
Ocera Therapeutics, Inc., formerly Tranzyme, Inc., incorporated on January 12, 1998, is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing mechanism-based therapeutics for the treatment of upper gastrointestinal (GI) motility disorders. The Company is developing TZP-102, an oral ghrelin agonist for treating the symptoms associated with chronic upper GI motility disorders. Enrollment is complete in a multinational Phase-IIb trial evaluating TZP-102 given once daily in diabetic patients with gastroparesis. The Company has initiated a second Phase-IIb trial (DIGEST) evaluating TZP-102 given prior to meals in diabetic patients with gastroparesis. On July 15, 2013, Ocera Therapeutics, Inc. merged with the Company.
Ulimorelin (Intravenous Ghrelin Agonist)
Ulimorelin is an intravenous ghrelin agonist in Phase III clinical development for the acceleration of postoperative GI recovery. Ulimorelin is designed to accelerate the return of normal GI function in patients suffering from acute GI disorders. In addition to the ongoing trials, the Company has completed multiple trials of ulimorelin.
TZP-102 (Oral Ghrelin Agonist)
TZP-102 is an orally-administered ghrelin agonist, which it is developing for diabetic gastroparesis, an upper GI motility disorder. Gastroparesis is a debilitating, chronic condition characterized by slow or delayed gastric emptying and gastric retention that can be caused by any disease that induces neuromuscular dysfunction of the GI tract, notably diabetes.
Advisors' Opinion:- [By Jon C. Ogg]
Ocera Therapeutics Inc. (NASDAQ: OCRX) was started as Buy with a $19.00 price target at Stifel Nicolaus. This represents 62% upside to the $11.70 closing price. This positive call is based on a best-in-class mechanism action of its lead product candidate against hepatic encephalopathy in patients with acute and chronic liver disease.
- [By Monica Gerson]
Ocera Therapeutics (NASDAQ: OCRX) plummeted 16.01% to $13.80. Ocera Therapeutics shares have jumped 158.33% over the past 52 weeks, while the S&P 500 index has gained 23.35% in the same period.
5 Best Supermarket Stocks To Watch For 2014: ITT Educational Services Inc (ESI)
ITT Educational Services, Inc. (ITT/ESI), incorporated in 1946, is a provider of postsecondary degree programs in the United States. As of December 31, 2011, the Company offered master, bachelor and associate degree programs to approximately 73,000 students. As of December 31, 2011, the Company had 144 locations (including 141 campuses and three learning sites) in 39 states. In addition, ITT/ESI offered one or more of its online programs to students who were located in 48 states. The Company designs its education programs, after consultation with employers and other constituents, to help graduates prepare for careers in various fields involving their areas of study. The Company provides career-oriented education programs under the Daniel Webster College (DWC) name. During the year ended December 31, 2011, it began operations at 11 new ITT Technical Institute campuses and discontinued operations at one learning site. As of December 31, 2011, the ITT Technical Institutes offered 55 degree programs in various fields of study across the schools of study, such as information technology (IT); electronics technology; drafting and design; business; criminal justice, and breckinridge school of nursing and health sciences. As of December 31, 2011, the Company had 144 locations (including 141 campuses and three learning sites) in 39 states, which provided postsecondary education to approximately 73,000 students. In 2011, the Company derived approximately 98% of its revenue from tuition and approximately 2% from the sale of tool kits and fees, charged to and paid by, or on behalf of, its students. On August 1, 2013, the Company announced that it has acquired Cable Holdings, LLC.
At most of its campuses, ITT/ESI organizes the academic schedule for programs of study on the basis of four 12-week academic quarters in a calendar year, with new students beginning at the start of each academic quarter. At these campuses, students taking a full-time course load can complete its associate degree programs in ! eight academic quarters, bachelor degree programs in 14 or 15 academic quarters and a master degree program in six or seven academic quarters. ITT/ESI offers classes in residence programs in 3.5- to 5.5-hour sessions three days a week, Monday through Saturday, with all program courses taught entirely or partially in residence; or sessions that are scheduled two to three days a week, Monday through Saturday, with certain program courses taught entirely or partially online over the Internet academic quarters. Depending on student enrollment, class sessions at the most of its campuses are available in the morning, afternoon and evening. The courses that are taught online over the Internet are delivered through an asynchronous learning network and have a prescribed schedule for completion of the coursework. In addition to courses directly related to a student�� program of study, its programs also include general education courses in the humanities, composition, mathematics, the sciences and the social sciences.
Advisors' Opinion:- [By GuruFocus]
This year�� underperformance was almost all caused by one single stock, ITT Educational Services (ESI). The market environment for the for-profit college has changed dramatically. It can�� make money as easily as it used to. The company�� business predictability dropped. This is the largest risk in investing in predictable companies.
- [By Dan Caplinger]
Outside the Dow, stocks generally rose somewhat more strongly. ITT Educational Services (NYSE: ESI ) soared 30% despite reporting decreasing new-student and total enrollment figures in its quarterly report. Net income dropped by nearly half on a 16% decline in revenue, but expectations were so low for the for-profit education company that those results managed to drive the stock higher. The episode is a good reminder that the beaten-down sector has plenty of room for growth if the worst-case scenarios for the industry don't play out.
- [By nnnguyen1221]
We all know it pays to get an education, but not all degrees are the same. For example, a bachelor�� in accounting is more likely to land a well-paying job than a bachelor�� in philosophy. The same may be true in the area of higher education. Does it pay to get into for-profit Higher Education? Let�� look at ITT Educational Services, Inc. (ESI) and see if this may mean a potential buying opportunity.
- [By Ben Levisohn]
Last week, ITT Educational Services (ESI) filed an 8-K disclosing that it was being investigated by the Consumer Financial Protection Bureau to determine whether it broke any rules in how it marketed loans.
ReutersThe filing, however, hasn’t had much of an impact. Shares of ITT Educational Services have dropped just 3.4% this week but have gained 95% so far in 2013. Corinthian Colleges (COCO), on the other hand, has dropped 27% this year, while DeVry Education (DV) has gained 50% and Apollo Education (APOL) has advanced 30%.
So why don’t investors care about the announcement? First of all, investors have known this was coming. Second, no one believes it will result in a damaging fine. William Blair’s Timo Connor explains:
We view as unlikely a severely punitive settlement against ITT Education from the Consumer Financial Protection Bureau (CFPB) related to its continuing investigation of marketing practices on third-party student lending programs, and we believe the risk is a manageable one for ITT. We continue to like the company�� competitive positioning in capacity-constrained, growing educational markets like drafting, electronics, IT, and nursing, and believe the stock will distance itself from legacy student loan issues in the coming years…
Connor‘s optimism also stems from previous penalties assessed by the CFPB: The median fine has been $3.9 million, or just 0.4% of ITT Educational Services market cap, Connor says.
Shares of ITT Educational Services have gained 1.8% to $33.87 today at 1:09 p.m., while Corinthian Colleges has risen 1.7% to $1.79, DeVry Education advanced 0.6% to $35.48 and Apollo Education has ticked down 0.1% to $27.17.
No comments:
Post a Comment